Assessment of PI3 kinase as a druggable target in melanoma

被引：0
|
作者：
Aziz, S. A.
Pick-Golan, E.
McCarthy, M. M.
Flaherty, K. T.
Camp, R. L.
Rimm, D. L.
Kluger, H. M.
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8521
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Mechanism for Synergy with Combined mTOR and PI3 Kinase Inhibitors
    Yang, Shujie
    Xiao, Xue
    Meng, Xiangbing
    Leslie, Kimberly K.
    PLOS ONE, 2011, 6 (10):
  • [32] PI3 Kinase Isoforms in Purinergic Mesenchymal Stromal Cells
    Kotova, P. D.
    Bystrova, M. F.
    BIOLOGICHESKIE MEMBRANY, 2020, 37 (02): : 156 - 160
  • [33] The role of PI3 kinase pathway in the the skin of Sezary syndrome
    Cristofoletti, Cristina
    Bresin, Antonella
    Picozza, Mario
    Picchio, Maria Cristina
    Passarelli, Francesca
    Monzo, Francesca
    Citterich, Mauro Helmer
    Monopoli, Alessandro
    Benucci, Roberto
    Cantonetti, Maria
    Frezzolini, Alessandra
    Scala, Enrico
    Caprini, Elisabetta
    Russo, Giandomenico
    Narducci, Maria Grazia
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Should individual PI3 kinase isoforms be targeted in cancer?
    Jia, Shidong
    Roberts, Thomas M.
    Zhao, Jean J.
    CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) : 199 - 208
  • [35] Inhibition of PI3 Kinase Gamma Enzyme by Novel Phenylpyrazoles
    Bepary, Sukumar
    Youn, In Kwon
    Lim, Hee-Jong
    Lee, Ge Hyeong
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (09): : 2829 - 2832
  • [36] Evolution of a series of potent and efficacious PI3 kinase inhibitors
    Heffron, Timothy P.
    Berry, Megan
    Castanedo, Georgette
    Chang, Christine
    Chuckowree, Irina
    Dotson, Jennafer
    Folkes, Adrian
    Gunzner, Janet
    Lesnick, John
    Lewis, Cristina
    Malesky, Kimberly
    Mathieu, Simon
    Nonomiya, Jim
    Olivero, Alan
    Pang, Jodie
    Peterson, David
    Salphati, Laurent
    Sampath, Deepak
    Sutherlin, Daniel P.
    Tsui, Vickie
    Ultsch, Mark
    Wan, Nan Chi
    Wang, Shumei
    Wiesmann, Christian
    Wong, Susan
    Zhu, Bing-yan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [37] PI3′-Kinase inhibition forestalls the development of drug resistance in BRAFV600E/PTENNull melanoma
    Deuker, M.
    Durban, V. Marsh
    Phillips, W.
    McMahon, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 100 - 100
  • [38] Galectin-1 modulates PI3 kinase activity
    Perry, James
    Chakravarti, Arnab
    Lautenschlaeger, Tim
    CANCER RESEARCH, 2010, 70
  • [39] The novel PI3 kinase inhibitor, BAY 80-6946, impairs melanoma growth in vivo and in vitro
    Schneider, Philine
    Schoen, Margarete
    Pletz, Nadin
    Seitz, Cornelia S.
    Liu, Ningshu
    Ziegelbauer, Karl
    Zachmann, Karolin
    Emmert, Steffen
    Schoen, Michael P.
    EXPERIMENTAL DERMATOLOGY, 2014, 23 (08) : 579 - 584
  • [40] PI3 kinase pathway during resistance to trastuzumab (Herception®)
    Darbon, Jean-Marie
    BULLETIN DU CANCER, 2008, 95 (03) : 268 - 268
12345